Cannabis Science Inc.
Cannabis Science Inc.
Cannabis Science Team
Careers & Corporate Culture
The Science of Cannabinoids
CBIS Cannabinoid Research
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
CBIS Bottle It
Products & Pharmacies
CBIS Current Share Structure
CBIS News Releases
CBIS In The News
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
: Creating default object from empty value in
Cannabis Science (CBIS) Ready For A Prosperous And Healthy New Year: 'The Best Is Yet To Come'
Cannabis Science (CBIS) Congratulates U.S. Congress for Historical Move to Stop the Department of Justice (DOJ) Impeding Legal State Medical Cannabis Operations; Perfect Timing for CBIS Large Investment in California
Cannabis Science (CBIS) Joins Forces With The Constituency For Africa (CFA) To Focus On Improving Healthcare Infrastructure In Africa In 2015
Cannabis Science (CBIS) Readies To Launch New Products In California With Apothocary Genetics
Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California
Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C.
Demand For Cannabis Science Drug Increases As Company Moves Into 2nd Stage Of Protocols For Pre-Clinical Drug Development, Thanks To Positive Laboratory Results From Its Operations In Spain
Cannabis Science, Inc. (CBIS) is in the Final Stages to Acquire A British Columbia Company That Has Submitted "Marihuana For Medical Purposes" Application to Health Canada (As Previously Announced)
Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant
Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis